CLINICAL_TRIALS
trial_result
· 2021-02-09
Clinical Trial Update: Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ
Summary
Post-marketing surveillance study assessing effectiveness and safety of Pristiq (desvenlafaxine) in major depressive disorder completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Major Depressive Disorder | Status: COMPLETED | Results posted: 2021-02-09